Shopping Cart
- Remove All
- Your shopping cart is currently empty
Dexpramipexole ((R)-Pramipexole), a BTZ structural analog of riluzole, is a mitochondrial protectant that maintains mitochondrial function and energy production, attenuates myocardial ischemia/reperfusion injury by up-regulating mitochondrial autophagy, and can be used in the treatment of amyotrophic lateral sclerosis disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $970 | In Stock |
Description | Dexpramipexole ((R)-Pramipexole), a BTZ structural analog of riluzole, is a mitochondrial protectant that maintains mitochondrial function and energy production, attenuates myocardial ischemia/reperfusion injury by up-regulating mitochondrial autophagy, and can be used in the treatment of amyotrophic lateral sclerosis disease. |
In vitro | Dexpramipexole is neuroprotective and has been used in research studies for the treatment of amyotrophic lateral sclerosis (ALS). Dexpramipexole reduces mitochondrial reactive oxygen species (ROS) production, inhibits activation of apoptotic pathways, and improves cell survival in response to a variety of neurotoxins and beta-amyloid neurotoxicity. Dexpramipexole is much less active than dopamine agonists of the S-(-) isomer. [1] |
Molecular Weight | 211.33 |
Formula | C10H17N3S |
Cas No. | 104632-28-2 |
Smiles | NC1=NC2=C(C[C@H](NCCC)CC2)S1 |
Relative Density. | 1.17 g/cm3 at 20℃ |
Storage | keep away from direct sunlight,store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 8 mg/mL (37.86 mM) | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.